Specifically, AML LSCs that were resistant to treatment with BET inhibitor in vitro were characterized by ULK1 activation.186 In contrast, no ULK1 activation was detected in cells sensitive to BET inhibitor treatment. Here, DNER is linked to acute myeloid leukemia.